P. А. Shesternya

643 total citations
34 papers, 159 citations indexed

About

P. А. Shesternya is a scholar working on Immunology, Rheumatology and Epidemiology. According to data from OpenAlex, P. А. Shesternya has authored 34 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 14 papers in Rheumatology and 4 papers in Epidemiology. Recurrent topics in P. А. Shesternya's work include Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). P. А. Shesternya is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Spondyloarthritis Studies and Treatments (8 papers) and Psoriasis: Treatment and Pathogenesis (7 papers). P. А. Shesternya collaborates with scholars based in Russia, Belarus and Ukraine. P. А. Shesternya's co-authors include М. М. Петрова, N. А. Shnayder, Е. А. Пожиленкова, Р. Ф. Насырова, Т. А. Раскина, В. Н. Максимов, Eun Young Lee, Jung‐Yoon Choe, Е. Л. Насонов and S. Radominski and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Molecules.

In The Last Decade

P. А. Shesternya

24 papers receiving 155 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. А. Shesternya Russia 6 75 56 30 26 20 34 159
Malorie Chabot-Blanchet Canada 7 77 1.0× 36 0.6× 7 0.2× 36 1.4× 5 0.3× 10 252
L. Méry‐Bossard France 6 100 1.3× 27 0.5× 7 0.2× 7 0.3× 13 0.7× 11 193
C. Florio Italy 9 60 0.8× 70 1.3× 17 0.6× 16 0.6× 7 0.3× 10 255
Luciano Ibba Italy 10 133 1.8× 47 0.8× 14 0.5× 5 0.2× 6 0.3× 36 264
Raili Müller Estonia 7 10 0.1× 101 1.8× 63 2.1× 7 0.3× 8 0.4× 12 188
Feng Ding China 8 108 1.4× 56 1.0× 31 1.0× 10 0.4× 1 0.1× 18 218
Maxime Hoffmann France 8 28 0.4× 17 0.3× 11 0.4× 6 0.2× 3 0.1× 11 220
Michaela Köhm Germany 7 60 0.8× 81 1.4× 27 0.9× 5 0.2× 2 0.1× 36 179
Buu Truong United States 9 20 0.3× 8 0.1× 18 0.6× 14 0.5× 3 0.1× 22 206
C. Papasteriades Greece 7 72 1.0× 36 0.6× 12 0.4× 6 0.2× 16 211

Countries citing papers authored by P. А. Shesternya

Since Specialization
Citations

This map shows the geographic impact of P. А. Shesternya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. А. Shesternya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. А. Shesternya more than expected).

Fields of papers citing papers by P. А. Shesternya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. А. Shesternya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. А. Shesternya. The network helps show where P. А. Shesternya may publish in the future.

Co-authorship network of co-authors of P. А. Shesternya

This figure shows the co-authorship network connecting the top 25 collaborators of P. А. Shesternya. A scholar is included among the top collaborators of P. А. Shesternya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. А. Shesternya. P. А. Shesternya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shesternya, P. А., et al.. (2025). Macrophage activation syndrome during pregnancy as a fatal complication of systemic idiopathic arthritis. Obstetrics Gynecology and Reproduction. 18(6). 898–907.
2.
Mease, Philip J., et al.. (2024). Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials. Rheumatology and Therapy. 11(6). 1551–1567. 1 indexed citations
3.
Shesternya, P. А., А. А. Баранов, Е. А. Богданова, et al.. (2024). Switching from interleukin-6 receptor inhibitors to the direct interleukin-6 inhibitor olokizumab in patients with rheumatoid arthritis: efficacy and safety during one year of therapy. SHILAP Revista de lepidopterología. 18(5). 54–64.
4.
Баранов, А. А., Е. А. Богданова, Е. П. Иливанова, et al.. (2023). Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab). SHILAP Revista de lepidopterología. 61(3). 307–319. 2 indexed citations
5.
Shesternya, P. А., et al.. (2022). Features of Peripheral Blood Th-Cell Subset Composition and Serum Cytokine Level in Patients with Activity-Driven Ankylosing Spondylitis. Pharmaceuticals. 15(11). 1370–1370. 3 indexed citations
6.
9.
Shesternya, P. А., et al.. (2021). PARALLEL PANDEMIC: PSYCHOLOGICAL FACILITATION IN MEDICAL ASSISTANCE. Sibirskiy psikhologicheskiy zhurnal. 156–167. 2 indexed citations
10.
Алексеева, Л. И., Е. А. Таскина, Н. В. Чичасова, et al.. (2021). The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study. SHILAP Revista de lepidopterología. 15(1). 51–59. 1 indexed citations
11.
Shesternya, P. А., et al.. (2020). Strategies and trends for organization of medical and psychological assistance in post-pandemic period. Siberian medical review. 5–10. 1 indexed citations
12.
Алексеева, Л. И., Е. А. Таскина, Т. А. Раскина, et al.. (2020). The efficacy and safety of intra-articular application of a combination of sodium hyaluronate and chondroitin sulfate for osteoarthritis of the knee: a multicenter prospective study. SHILAP Revista de lepidopterología. 92(5). 46–54. 5 indexed citations
13.
Vi, Mazurov, Ш. Ф. Эрдес, P. А. Shesternya, et al.. (2018). OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study. Annals of the Rheumatic Diseases. 77. 64–64. 7 indexed citations
14.
Shesternya, P. А., et al.. (2017). GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Shesternya, P. А., et al.. (2017). New horizons in the use of biological agents during pregnancy in patients with rheumatic disease. Terapevticheskii arkhiv. 89(5). 105–112.
18.
Shesternya, P. А., et al.. (2014). CLINICAL SIGNIFICANCE OF CORONARY ARTERY DISEASE GENETIC MARKERS: REALITY OR FAR FUTURE?. Russian Journal of Cardiology. 7–7. 2 indexed citations
19.
Shesternya, P. А., et al.. (2012). PREDICTIVE ROLE OF CHROMOSOME 9P21.3 POLYMORPHISMS AND THEIR ASSOCIATION WITH FAMILY HISTORY OF CORONARY HEART DISEASE IN PATIENTS WITH MYOCARDIAL INFARCTION. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Shesternya, P. А., et al.. (2010). Association of ADRB1 Gene Polymorphism with Atrial Fibrillation. Genetic Testing and Molecular Biomarkers. 14(2). 249–253. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026